MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,202,000 | -61.7% | 33,952 | -63.2% | 0.00% | -66.7% |
| Q4 2014 | $3,139,000 | -30.4% | 92,145 | -21.2% | 0.00% | -40.0% |
| Q3 2014 | $4,513,000 | -41.1% | 116,996 | -40.6% | 0.01% | -44.4% |
| Q2 2014 | $7,661,000 | -21.8% | 196,821 | -31.4% | 0.01% | -30.8% |
| Q1 2014 | $9,802,000 | +84.9% | 286,707 | +13.5% | 0.01% | +85.7% |
| Q4 2013 | $5,301,000 | +7.9% | 252,686 | +20.9% | 0.01% | 0.0% |
| Q3 2013 | $4,911,000 | -1.2% | 208,999 | +13.0% | 0.01% | -12.5% |
| Q2 2013 | $4,969,000 | – | 184,906 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |